Robotic cardiac surgical systems maker Stereotaxis, Inc. (NSDQ:STXS) watched its share price plunge hard and fast as it suspended 2011 guidance on a weak second quarter earnings report.
Shares sank 58 percent from Monday’s close of $2.85 to $1.19 at the end of the day yesterday, inching toward the company’s 52-week low of $1.11.